Karyopharm Therapeutics, Inc. (KPTI)
1.79
+0.02
(+1.13%)
USD |
NASDAQ |
Sep 04, 16:00
1.79
0.00 (0.00%)
After-Hours: 19:16
Karyopharm Therapeutics Cash and Short Term Investments (Annual) : 63.74M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 63.74M |
| December 31, 2024 | 108.74M |
| December 31, 2023 | 192.10M |
| December 31, 2022 | 279.03M |
| December 31, 2021 | 234.96M |
| December 31, 2020 | 251.72M |
| December 31, 2019 | 263.07M |
| December 31, 2018 | 328.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 146.67M |
| December 31, 2016 | 129.55M |
| December 31, 2015 | 175.63M |
| December 31, 2014 | 205.72M |
| December 31, 2013 | 155.97M |
| December 31, 2012 | 159.53M |
| December 31, 2011 | 6.512M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 988.65M |
| Relay Therapeutics, Inc. | 554.52M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |